Works matching AU Radich, Jerald P.

Results: 68
    1

    AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.

    Published in:
    Biomarker Research, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40364-020-00208-1
    By:
    • Pogosova-Agadjanyan, Era L.;
    • Moseley, Anna;
    • Othus, Megan;
    • Appelbaum, Frederick R.;
    • Chauncey, Thomas R.;
    • Chen, I-Ming L.;
    • Erba, Harry P.;
    • Godwin, John E.;
    • Jenkins, Isaac C.;
    • Fang, Min;
    • Huynh, Mike;
    • Kopecky, Kenneth J.;
    • List, Alan F.;
    • Naru, Jasmine;
    • Radich, Jerald P.;
    • Stevens, Emily;
    • Willborg, Brooke E.;
    • Willman, Cheryl L.;
    • Wood, Brent L.;
    • Zhang, Qing
    Publication type:
    Article
    2
    3
    4
    5
    6

    Identification of genes with abnormal expression changes in acute myeloid leukemia.

    Published in:
    Genes, Chromosomes & Cancer, 2008, v. 47, n. 1, p. 8, doi. 10.1002/gcc.20500
    By:
    • Stirewalt, Derek L.;
    • Meshinchi, Soheil;
    • Kopecky, Kenneth J.;
    • Fan, Wenhong;
    • Pogosova-Agadjanyan, Era L.;
    • Engel, Julia H.;
    • Cronk, Michelle R.;
    • Dorcy, Kathleen Shannon;
    • McQuary, Amy R.;
    • Hockenbery, David;
    • Wood, Brent;
    • Heimfeld, Shelly;
    • Radich, Jerald P.
    Publication type:
    Article
    7

    Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms.

    Published in:
    2019
    By:
    • Mughal, Tariq I.;
    • Pemmaraju, Naveen;
    • Radich, Jerald P.;
    • Deininger, Michael W.;
    • Kucine, Nicole;
    • Kiladjian, Jean‐Jacques;
    • Bose, Prithviraj;
    • Gotlib, Jason;
    • Valent, Peter;
    • Chen, Chih‐Cheng;
    • Barbui, Tiziano;
    • Rampal, Raajit;
    • Verstovsek, Srdan;
    • Koschmieder, Steffen;
    • Saglio, Giuseppe;
    • Van Etten, Richard A.;
    • Kiladjian, Jean-Jacques;
    • Chen, Chih-Cheng
    Publication type:
    journal article
    8

    Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 5, p. 945, doi. 10.1007/s00432-018-2604-x
    By:
    • Ross, David M.;
    • Masszi, Tamas;
    • Gómez Casares, María Teresa;
    • Hellmann, Andrzej;
    • Stentoft, Jesper;
    • Conneally, Eibhlin;
    • Garcia-Gutierrez, Valentin;
    • Gattermann, Norbert;
    • le Coutre, Philipp D.;
    • Martino, Bruno;
    • Saussele, Susanne;
    • Giles, Francis J.;
    • Radich, Jerald P.;
    • Saglio, Giuseppe;
    • Deng, Weiping;
    • Krunic, Nancy;
    • Bédoucha, Véronique;
    • Gopalakrishna, Prashanth;
    • Hochhaus, Andreas
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report.

    Published in:
    EJHaem, 2024, v. 5, n. 6, p. 1243, doi. 10.1002/jha2.1041
    By:
    • Naru, Jasmine;
    • Othus, Megan;
    • Lin, ChenWei;
    • Biernacki, Melinda A.;
    • Bleakley, Marie;
    • Chauncey, Thomas R.;
    • Erba, Harry P.;
    • Fang, Min;
    • Fitzgibbon, Matthew P.;
    • Gafken, Phillip R.;
    • Ivey, Richard G.;
    • Kennedy, Jacob J.;
    • Lorentzen, Travis D.;
    • Meshinchi, Soheil;
    • Moseley, Anna;
    • Pogosova‐Agadjanyan, Era L.;
    • Liu, Vivian M.;
    • Radich, Jerald P.;
    • Voytovich, Uliana J.;
    • Wang, Pei
    Publication type:
    Article
    18
    19

    Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantation.

    Published in:
    Science Translational Medicine, 2024, v. 16, n. 770, p. 1, doi. 10.1126/scitranslmed.ado5108
    By:
    • Oshima, Masumi Ueda;
    • Higgins, Jacob;
    • Jenkins, Isaac;
    • Randolph, Timothy;
    • Smith, Thomas;
    • Valentine III, Charles;
    • Salk, Jesse;
    • Yeung, Cecilia;
    • Beppu, Lan;
    • Campbell, Judy;
    • Carpenter, Paul A.;
    • Lee, Stephanie J.;
    • Flowers, Mary E.;
    • Radich, Jerald P.;
    • Storb, Rainer
    Publication type:
    Article
    20
    21

    Treatment-Free Remission (TFR) Following Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): 192-Weeks Data from the ENESTfreedom Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S288, doi. 10.1016/j.clml.2019.07.232
    By:
    • Radich, Jerald P.;
    • Ross, David M.;
    • Masszi, Tamas;
    • Gómez Casares, María Teresa;
    • Hellmann, Andrzej;
    • Stentoft, Jesper;
    • Conneally, Eibhlin;
    • Gutierrez, Valentin García;
    • Gattermann, Norbert;
    • Le Coutre, Philipp D.;
    • Martino, Bruno;
    • Saussele, Susanne;
    • Giles, Francis J.;
    • Saglio, Giuseppe;
    • Sondhi, Manu;
    • Mishra, Kaushal;
    • Aimone, Paola;
    • Hochhaus, Andreas
    Publication type:
    Article
    22
    23

    ENESTfreedom 144-Week Update: Long-Term Treatment-Free Remission (TFR) Following Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S226, doi. 10.1016/j.clml.2018.07.099
    By:
    • Radich, Jerald P.;
    • Masszi, Tamás;
    • Gómez Casares, María Teresa;
    • Hellmann, Andrzej;
    • Stentoft, Jesper;
    • Conneally, Eibhlin;
    • Gutierrez, Valentín Garcia;
    • Gattermann, Norbert;
    • le Coutre, Philipp D.;
    • Martino, Bruno;
    • Saussele, Susanne;
    • Giles, Francis J.;
    • Ross, David M.;
    • Saglio, Giuseppe;
    • Sondhi, Manu;
    • Acharyya, Suddhasatta;
    • Chaturvedi, Shalini;
    • Bédoucha, Véronique;
    • Hochhaus, Andreas
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31

    Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2014, v. 164, n. 2, p. 223, doi. 10.1111/bjh.12618
    By:
    • Deininger, Michael W.;
    • Kopecky, Kenneth J.;
    • Radich, Jerald P.;
    • Kamel‐Reid, Suzanne;
    • Stock, Wendy;
    • Paietta, Elisabeth;
    • Emanuel, Peter D.;
    • Tallman, Martin;
    • Wadleigh, Martha;
    • Larson, Richard A.;
    • Lipton, Jeffrey H.;
    • Slovak, Marilyn L.;
    • Appelbaum, Frederick R.;
    • Druker, Brian J.
    Publication type:
    Article
    32
    33
    34

    Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.

    Published in:
    2018
    By:
    • Atallah, Ehab;
    • Schiffer, Charles A.;
    • Weinfurt, Kevin P.;
    • Zhang, Mei-Jie;
    • Radich, Jerald P.;
    • Oehler, Vivian G.;
    • Pinilla-Ibarz, Javier;
    • Deininger, Michael W. N.;
    • Li Lin;
    • Larson, Richard A.;
    • Mauro, Michael J.;
    • Moore, Joseph O.;
    • Ritchie, Ellen K.;
    • Shah, Neil P.;
    • Silver, Richard T.;
    • Wadleigh, Martha;
    • Cortes, Jorge;
    • Thompson, James;
    • Guhl, Jessica;
    • Horowitz, Mary M.
    Publication type:
    journal article
    35
    36
    37
    38
    39

    Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study.

    Published in:
    2014
    By:
    • Baccarani, Michele;
    • Druker, Brian J;
    • Branford, Susan;
    • Kim, Dong-Wook;
    • Pane, Fabrizio;
    • Mongay, Lidia;
    • Mone, Manisha;
    • Ortmann, Christine-Elke;
    • Kantarjian, Hagop M;
    • Radich, Jerald P;
    • Hughes, Timothy P;
    • Cortes, Jorge E;
    • Guilhot, François
    Publication type:
    journal article
    40
    41
    42
    43
    44
    45
    46
    47

    The Role of Transplant in CML.

    Published in:
    Clinical Advances in Hematology & Oncology, 2013, v. 11, n. 11, p. 11
    By:
    • Radich, Jerald P.
    Publication type:
    Article
    48
    49
    50